Characterization and clinical application of human CD34+ stem/progenitor cell populations mobilized into the blood by granulocyte colony-stimulating factor

Stem Cells

Volumn 24, Issue 7, 2006, Pages 1822-1830

  Gordon, Myrtle Y ^a,b   Levičar, Nataša ^a   Pai, Madhava ^a   Bachellier, Philippe ^a   Dimarakis, Ioannis ^a   Al Allaf, Faisal ^a   M'Hamdi, Hanane ^a   Thalji, Tamara ^a   Welsh, Jonathan P ^a   Marley, Stephen B ^a   Davies, John ^a   Dazzi, Francesco ^a   Marelli Berg, Federica ^a   Tait, Paul ^a   Playford, Raymond ^a   Jiao, Long ^a   Jensen, Steen ^a   Nicholls, Joanna P ^a,b   Ayav, Ahmet ^a   Nohandani, Mahrokh ^a   Farzaneh, Farzin ^c   Gaken, Joop ^c   Dodge, Rikke ^d   Alison, Malcolm ^e   Apperley, Jane F ^a   Lechler, Robert ^c   Habib, Nagy A ^a,b   more..

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b LiverCyte Limited   (United Kingdom)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d JOSLIN DIABETES CENTER   (United States)

^e ROYAL LONDON HOSPITAL   (United Kingdom)

Author keywords

Liver disease; Regenerative medicine; Stem cells; Transplantation

Indexed keywords

CD34 ANTIGEN; GRANULOCYTE COLONY STIMULATING FACTOR;

ABSENCE OF SIDE EFFECTS; ADULT; ARTICLE; CELL DIFFERENTIATION; CELL MOTILITY; CELL POPULATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; GENE EXPRESSION; HEMATOPOIESIS; HUMAN; IMMUNOPHENOTYPING; LEUKAPHERESIS; LIVER FAILURE; MALE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEM CELL; TISSUE REGENERATION; ALCOHOL LIVER DISEASE; BLOOD; CELL ADHESION; CELL CULTURE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; METABOLISM; MIDDLE AGED; MULTIPOTENT STEM CELL; PARASITIC LIVER DISEASE; PHASE 1 CLINICAL TRIAL; PHYSIOLOGY; STEM CELL MOBILIZATION;

ANTIGENS, CD34; CELL ADHESION; CELL DIFFERENTIATION; CELLS, CULTURED; FEMALE; GENE EXPRESSION; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LIVER DISEASES, ALCOHOLIC; LIVER DISEASES, PARASITIC; MALE; MIDDLE AGED; MULTIPOTENT STEM CELLS;

EID: 33749054952     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1634/stemcells.2005-0629     Document Type: Article

References (26)

1. Preston SL, Alison MR, Forbes SJ et al. The new stem cell biology: Something for everyone. Mol Pathol 2003;56:86-96.
2. Fujikawa T, Oh SH, Pi L et al. Teratoma formation leads to failure of treatment for type I diabetes using embryonic stem cell-derived insulin-producing cells. Am J Pathol 2005;166:1781-1791.
3. Shenfield F. Semantics and ethics of human embryonic stem-cell research. Lancet 2005;365:2071-2073.
4. Friedenstein AJ, Chailakhyan RK, Latsinik NV et al. Stromal cells responsible for transferring the microenvironment of the haemopoietic tissues: Cloning in vitro and retransplantation in vivo. Transplantation 1974;17:331-340.
5. Reyes M, Verfaillie CM. Characterization of multipotent adult progenitor cells, a subpopulation of mesenchymal stem cells. Ann N Y Acad Sci 2001;938:231-235.
6. Kogler G, Sensken S, Aireq JA et al. A new human somatic stem cells from placental cord blood with intrinsic pluripotent differentiation potential. J Exp Med 2004;200:123-135.
7. Colter D, Class R, DiGirolama CM et al. Rapid expansion of recycling stem cells in cultures of plastic adherent cells from human marrow. Proc Natl Acad Sci U S A 2000;96:7294-7299.
8. Colter DC, Sekiya I, Prockop DJ. Identification of a subpopulation of rapidly self-renewing and multipotential adult stem cells in colonies of human marrow stromal cells. Proc Natl Acad Sci U S A 2001;98:7841-7845.
9. Quesenberry PJ, Dooner G, Colvin G et al. Stem cell biology and the plasticity polemic. Exp Hematol 2005;33:389-394.
10. Smith JR, Pochampally R, Perry A et al. Isolation of a highly clonogenic and multipotential subfraction of adult stem cells from bone marrow stroma. STEM CELLS 2004;22:823-831.
11. Thomas ED. Bone marrow transplantation from a personal viewpoint. Int J Hematol 2005;81:89-93.
12. + bone marrow cells to the liver: A novel concept to support hepatic regeneration. STEM CELLS 2005;23:463-470.
13. Wang JS, Shum-Tim D, Chedrawy E et al. The coronary delivery of marrow stromal cells for myocardial infarction: Pathophysiologic and therapeutic implications. J Thorac Cardiovasc Surg 2001;122:699-705.
14. Pomyje J, Zivny J, Sefc L et al. Expression of genes regulating angiogenesis in human circulating hematopoietic cord blood cells. Eur J Hematol 2003;70:143-150.
15. Weber KS, Alon R, Klickstein LB. Sialylation of ICAM-2 on platelets impairs adhesion of leukocytes via LFA-1 and DC-SIGN. Inflammation 2004;28:177-188.
16. Cross MA, Enver T. The lineage commitment of haemopoietic progenitor cells. Curr Opin Genet Dev 1997;7:609-613.
17. Snyder EY, Daley GQ, Goodell M. Taking stock and planning for the next decade: Realistic prospects for stem cell therapies for the nervous system. J Neurosci Res 2004;76:157-168.
18. Colvin GA, Lambert JF, Moore BE et al. Pronounced heterogeneity of clonally derived purified murine marrow stem cells. Exp Hematol 2004;32(suppl 1):62.
19. Marley SB, Lewis JL, Gordon MY. Progenitor cells divide symmetrically to generate new colony-forming cells and clonal heterogeneity. Br J Haematol 2003;121:643-648.
20. Jiang Y, Jahagirdar BN, Reinhardt RL et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 2002;418:41-49.
21. Till JE, McCulloch EA. A direct measurement of the radiation sensitivity of normal mouse bone marrow cells. Radiat Res 1961;14:213.
22. Gordon MY, Barrett AJ. Bone Marrow Disorders: The Biological Basis of Clinical Problems. Oxford, U.K.: Blackwell Scientific Publications, 1985:104-136.
23. Charbourd P, Gown AM, Keating A et al. CGA-7 and HHF, two monoclonal antibodies that recognise muscle actin and react with adherent cells in human long-term bone marrow cultures. Blood 1985;66:1138-1142.
24. Short B, Brouard N, Occhiodoro-Scott T et al. Mesenchymal stem cells. Arch Med Res 2003;34:565-571.
25. Roberts AW, Metcalf D. Noncycling state of peripheral blood progenitor cells mobilized by granulocyte colony-stimulating factor and other cytokines. Blood 1995;86:1600-1605.
26. Scott MA, Apperley JF, Bloxham DM et al. Biological properties of peripheral blood progenitor cells mobilized by cyclophosphamide and granulocyte colony-stimulating factor. Br J Haematol 1997;97:474-480.